CRP Vario
C-Reactive Protein, Antigen, Antiserum, And Control. 510(k) K192118, from SENTINEL CH. SpA (Milan, IT). Product code DCK, class 2.
As of Nov 17, 2026, K192118 is an FDA 510(k) held by SENTINEL CH. SpA, substantially equivalent on Nov 8, 2019 after 94 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Nov 8, 2019
- Review time: 94 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe CRP Vario assay [CRPVa] is for in vitro diagnostic use in the quantitative immunoturbidimetric determination of C-reactive protein in human serum and plasma (sodium and lithium heparin) using the ARCHITECT c Systems. Measurement of C-reactive protein is useful in the detection and evaluation of infection, tissue injury and inflammatory disorders.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Crp Diagnostic AssayK050836 · Sentinel Ch. Srl · Aug 8, 2005
- Olympus Crp Latex Reagent, OSR6199; Olympus Crp Latex Calibrator Normal Set, ODC0026;…K051564 · Olympus America, Inc. · Aug 22, 2005
- AU5800(R) Chemistry AnalyzerK112412 · Beckman Coulter, Inc. · Dec 23, 2011
Other DCK Clearances
The newest 510(k)s for the same product code; see every DCK device- K-ASSAY CRP (Ver.2)K242170 · Kamiya Biomedical Company, LLC · Apr 18, 2025
- Procise CRP, ProciseDx Analyzer, ProciseDx Calibration CartridgeK201256 · Procise Diagnostics · Nov 4, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Aug 6, 2019
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5270
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files